Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 8, Issue 1
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
XML
Clinical/translational cancer immunotherapy
Original research
Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition
Online download statistics by month:
Online download statistics by month: June 2020 to March 2024
Abstract
Full
Pdf
Jun 2020
160
160
56
Jul 2020
149
149
52
Aug 2020
98
96
34
Sep 2020
109
109
75
Oct 2020
140
140
51
Nov 2020
121
120
48
Dec 2020
141
141
36
Jan 2021
161
161
54
Feb 2021
155
155
48
Mar 2021
251
251
88
Apr 2021
227
227
44
May 2021
187
187
50
Jun 2021
174
174
85
Jul 2021
133
133
38
Aug 2021
113
114
41
Sep 2021
162
162
57
Oct 2021
128
129
76
Nov 2021
135
135
51
Dec 2021
146
147
51
Jan 2022
143
146
35
Feb 2022
100
104
45
Mar 2022
90
98
32
Apr 2022
124
132
42
May 2022
156
159
69
Jun 2022
130
133
53
Jul 2022
125
140
50
Aug 2022
122
128
53
Sep 2022
101
104
67
Oct 2022
96
103
36
Nov 2022
143
148
47
Dec 2022
91
92
21
Jan 2023
87
89
31
Feb 2023
117
118
41
Mar 2023
112
115
45
Apr 2023
53
57
34
May 2023
51
52
21
Jun 2023
65
66
27
Jul 2023
64
68
34
Aug 2023
85
90
39
Sep 2023
64
64
22
Oct 2023
155
156
32
Nov 2023
229
229
29
Dec 2023
76
77
23
Jan 2024
48
49
27
Feb 2024
72
74
42
Mar 2024
91
92
47
Total
5680
5773
2079
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?